Analysis of current status of prophylactic anticoagulation in patients with venous thromboembolism after lung surgery: a single center study
10.3760/cma.j.cn112434-20190904-00298
- VernacularTitle:肺外科术后静脉血栓栓塞症预防性抗凝现状分析：单中心研究结果
- Author:
Songping CUI
1
;
Bo TIAN
;
Hui LI
;
Chunfeng SONG
;
Bin HU
Author Information
1. 首都医科大学附属北京朝阳医院胸外科 100020
- From:
Chinese Journal of Thoracic and Cardiovascular Surgery
2020;36(11):678-681
- CountryChina
- Language:Chinese
-
Abstract:
Objective:To identify the characteristics of venous thromboembolism(VTE) after lung surgery and the use of prophylactic anticoagulants. Inclusion criteria: (1) patients with primary pulmonary disease; (2) received pulmonary surgery; (3) Doppler ultrasound examination of lower extremity veins before and after operation.Methods:Patients who underwent lung surgery in our department from July 2016 to December 2017 were studied retrospectively.Results:A total of 659 patients who underwent lung surgery were analyzed, of which 58 patients had new diagnosis of VTE, after surgery with an incidence of 8.8%, and 151 patients were treated with prophylactic anticoagulants, with a total prophylactic use rate of 22.9%. According to the modified Caprini risk assessment scale, the patients were divided into three groups: low risk group(≤4 points), medium risk group(5-8 points) and high risk group(≥9 points). The proportion of prophylactic anticoagulation in each group was 4.0%(12/300), 36.3%(119/328) and 64.5%(20/31), respectively. The duration of prophylactic anticoagulation was also quite different, including 99 patients with anticoagulation for 1-3 days, 46 for 4-6 days, and 6 for 7-9 days. There was no significant difference in the incidence of VTE between patients who received prophylactic anticoagulation and patients who did not receive prophylactic anticoagulation( P>0.05). Conclusion:The incidence of VTE after pulmonary surgery is high, but the proportion of patients receiving prophylactic anticoagulation is low, and the anticoagulation course is too short, which leads to the poor preventive effect. It is suggested that the use of anticoagulants should be reasonably standardized in the future in order to improve the state of blood coagulation and prevent thrombosis.
